Update: 14.05.2024
Last week: 18 week 2024 (29.04.2024 - 04.05.2024)
Last full month: April 2024
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 5 975 | -31.2% | 11.5% | -0.7 | 13 140 497 | -30.9% | 9.7% | -0.6 | -26.9% |
| MoM | 36 442 | 6.8% | 11.5% | 1 | 80 510 850 | 4.8% | 9.7% | 0.8 | -2.7% |
| YTD | 130 907 | 22.8% | 11.1% | 2.4 | 292 563 853 | 51.9% | 9.5% | 2.2 | -4.0% |
| MAT | 365 136 | 31.4% | 9.9% | 1.8 | 756 845 731 | 48.8% | 8.4% | 1.5 | 7.8% |
| BRAINMAX | |||||||||
| WoW | 843 | -30.4% | 100.0% | 0 | 3 076 464 | -30.7% | 100.0% | 0 | -30.4% |
| MoM | 5 008 | 6.7% | 100.0% | 0 | 17 994 700 | 5.5% | 100.0% | 0 | 17.9% |
| YTD | 18 512 | 49.0% | 100.0% | 0 | 66 729 905 | 58.7% | 100.0% | 0 | 49.0% |
| MAT | 52 742 | 133.3% | 100.0% | NA | 185 673 339 | 148.1% | 100.0% | NA | NA |
| GOLDLINE PLUS | |||||||||
| WoW | 15 255 | -19.0% | 45.2% | -0.5 | 48 448 500 | -18.3% | 37.4% | 0 | -18.0% |
| MoM | 79 648 | -0.5% | 45.8% | 1 | 250 870 960 | -0.3% | 37.3% | 1.2 | -2.7% |
| YTD | 305 804 | -0.5% | 44.5% | 1.7 | 974 105 396 | 4.5% | 36.4% | -2.5 | -4.3% |
| MAT | 867 373 | 14.5% | 45.6% | 1.7 | 2 733 987 155 | 23.1% | 38.7% | 0 | 10.1% |
| MIGRENIUM | |||||||||
| WoW | 11 002 | -20.2% | 0.6% | 0 | 3 580 929 | -19.0% | 0.8% | 0 | -15.2% |
| MoM | 61 140 | 15.8% | 0.6% | 0.1 | 19 318 134 | 20.2% | 0.9% | 0.2 | -6.0% |
| YTD | 224 576 | 2.0% | 0.6% | -0.1 | 66 107 137 | 66.6% | 0.7% | 0.2 | 17.0% |
| MAT | 645 923 | 7.3% | 0.5% | 0 | 149 084 698 | 36.4% | 0.5% | 0 | 16.4% |
| MODELAX-N | |||||||||
| WoW | 25 258 | -19.5% | 23.0% | -1.5 | 11 122 406 | -19.0% | 15.2% | -1 | -14.1% |
| MoM | 137 404 | -16.6% | 24.9% | -2.5 | 59 188 675 | -14.0% | 16.3% | -1.2 | -8.3% |
| YTD | 569 316 | 53.8% | 23.8% | 5.8 | 236 200 228 | 102.9% | 15.0% | 4.8 | 16.4% |
| MAT | 1 367 240 | 98.3% | 20.7% | 7.8 | 502 599 911 | 124.1% | 12.1% | 4.8 | 23.9% |
| REDUXIN | |||||||||
| WoW | 10 957 | -19.0% | 32.5% | -0.4 | 57 918 497 | -19.9% | 44.7% | -0.9 | -18.0% |
| MoM | 56 729 | -3.8% | 32.6% | -0.4 | 306 452 225 | -5.6% | 45.6% | -1.1 | -2.7% |
| YTD | 227 270 | -8.1% | 33.1% | -1.4 | 1 233 922 035 | 21.5% | 46.1% | 3.7 | -4.3% |
| MAT | 617 775 | 1.3% | 32.4% | -2.8 | 3 091 469 801 | 22.7% | 43.7% | -0.1 | 10.1% |
| REDUXIN FORTE | |||||||||
| WoW | 3 075 | -17.3% | 9.1% | 0.1 | 13 144 785 | -15.9% | 10.1% | 0.3 | -18.0% |
| MoM | 15 157 | -2.0% | 8.7% | 0.1 | 64 576 943 | -3.1% | 9.6% | 0 | -2.7% |
| YTD | 59 843 | 4.8% | 8.7% | 0.8 | 260 767 437 | 22.4% | 9.7% | 0.8 | -4.3% |
| MAT | 168 753 | 25.4% | 8.9% | 1.1 | 701 247 295 | 37.8% | 9.9% | 1.1 | 10.1% |
| SALVISAR | |||||||||
| WoW | 11 893 | -18.3% | 1.7% | -0.1 | 5 043 690 | -16.9% | 1.6% | 0 | -14.6% |
| MoM | 59 234 | 14.4% | 1.7% | 0.2 | 24 423 069 | 19.0% | 1.6% | 0.2 | 1.1% |
| YTD | 188 536 | -2.9% | 1.4% | -0.1 | 73 407 036 | 17.3% | 1.2% | 0 | 4.5% |
| MAT | 492 674 | -17.2% | 1.2% | -0.4 | 174 563 640 | -13.7% | 1.0% | -0.4 | 7.6% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 130 907 | 22.8% | 11.1% | 2.4 | 292 563 853 | 51.9% | 9.5% | 2.2 | -4.0% |
| BRAINMAX | 18 512 | 49.0% | 100.0% | 0 | 66 729 905 | 58.7% | 100.0% | 0 | 49.0% |
| GOLDLINE PLUS | 305 804 | -0.5% | 44.5% | 1.7 | 974 105 396 | 4.5% | 36.4% | -2.5 | -4.3% |
| MIGRENIUM | 224 576 | 2.0% | 0.6% | -0.1 | 66 107 137 | 66.6% | 0.7% | 0.2 | 17.0% |
| MODELAX-N | 569 316 | 53.8% | 23.8% | 5.8 | 236 200 228 | 102.9% | 15.0% | 4.8 | 16.4% |
| REDUXIN CAPS | 227 270 | -8.1% | 33.1% | -1.4 | 1 233 922 035 | 21.5% | 46.1% | 3.7 | -4.3% |
| REDUXIN FORTE | 59 843 | 4.8% | 8.7% | 0.8 | 260 767 437 | 22.4% | 9.7% | 0.8 | -4.3% |
| SALVISAR | 188 536 | -2.9% | 1.4% | -0.1 | 73 407 036 | 17.3% | 1.2% | 0 | 4.5% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 365 136 | 31.4% | 9.9% | 1.8 | 756 845 731 | 48.8% | 8.4% | 1.5 | 7.8% |
| BRAINMAX | 52 742 | 133.3% | 100.0% | NA | 185 673 339 | 148.1% | 100.0% | NA | NA |
| GOLDLINE PLUS | 867 373 | 14.5% | 45.6% | 1.7 | 2 733 987 155 | 23.1% | 38.7% | 0 | 10.1% |
| MIGRENIUM | 645 923 | 7.3% | 0.5% | 0 | 149 084 698 | 36.4% | 0.5% | 0 | 16.4% |
| MODELAX-N | 1 367 240 | 98.3% | 20.7% | 7.8 | 502 599 911 | 124.1% | 12.1% | 4.8 | 23.9% |
| REDUXIN CAPS | 617 775 | 1.3% | 32.4% | -2.8 | 3 091 469 801 | 22.7% | 43.7% | -0.1 | 10.1% |
| REDUXIN FORTE | 168 753 | 25.4% | 8.9% | 1.1 | 701 247 295 | 37.8% | 9.9% | 1.1 | 10.1% |
| SALVISAR | 492 674 | -17.2% | 1.2% | -0.4 | 174 563 640 | -13.7% | 1.0% | -0.4 | 7.6% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 5 975 | -31.2% | 11.5% | -0.7 | 13 140 497 | -30.9% | 9.7% | -0.6 | -26.9% |
| BRAINMAX | 843 | -30.4% | 100.0% | 0 | 3 076 464 | -30.7% | 100.0% | 0 | -30.4% |
| GOLDLINE PLUS | 15 255 | -19.0% | 45.2% | -0.5 | 48 448 500 | -18.3% | 37.4% | 0 | -18.0% |
| MIGRENIUM | 11 002 | -20.2% | 0.6% | 0 | 3 580 929 | -19.0% | 0.8% | 0 | -15.2% |
| MODELAX-N | 25 258 | -19.5% | 23.0% | -1.5 | 11 122 406 | -19.0% | 15.2% | -1 | -14.1% |
| REDUXIN CAPS | 10 957 | -19.0% | 32.5% | -0.4 | 57 918 497 | -19.9% | 44.7% | -0.9 | -18.0% |
| REDUXIN FORTE | 3 075 | -17.3% | 9.1% | 0.1 | 13 144 785 | -15.9% | 10.1% | 0.3 | -18.0% |
| SALVISAR | 11 893 | -18.3% | 1.7% | -0.1 | 5 043 690 | -16.9% | 1.6% | 0 | -14.6% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 36 442 | 6.8% | 11.5% | 1 | 80 510 850 | 4.8% | 9.7% | 0.8 | -2.7% |
| BRAINMAX | 5 008 | 6.7% | 100.0% | 0 | 17 994 700 | 5.5% | 100.0% | 0 | 17.9% |
| GOLDLINE PLUS | 79 648 | -0.5% | 45.8% | 1 | 250 870 960 | -0.3% | 37.3% | 1.2 | -2.7% |
| MIGRENIUM | 61 140 | 15.8% | 0.6% | 0.1 | 19 318 134 | 20.2% | 0.9% | 0.2 | -6.0% |
| MODELAX-N | 137 404 | -16.6% | 24.9% | -2.5 | 59 188 675 | -14.0% | 16.3% | -1.2 | -8.3% |
| REDUXIN CAPS | 56 729 | -3.8% | 32.6% | -0.4 | 306 452 225 | -5.6% | 45.6% | -1.1 | -2.7% |
| REDUXIN FORTE | 15 157 | -2.0% | 8.7% | 0.1 | 64 576 943 | -3.1% | 9.6% | 0 | -2.7% |
| SALVISAR | 59 234 | 14.4% | 1.7% | 0.2 | 24 423 069 | 19.0% | 1.6% | 0.2 | 1.1% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs